CorVel (CRVL) Launches Marketwise Repricing As Fair Value Questions Return
CorVel (CRVL) has launched Marketwise Repricing, a new medical bill repricing tool designed for complex billing scenarios. Despite short-term stock momentum (up 15.02% in 90 days), the company's one-year total shareholder return is down 40.91%. The article discusses whether CRVL, trading at a P/E of 28.3x, is undervalued given its new product and strong revenue, especially when compared to its peers and its discounted cash flow model estimate of $97.39 per share.
CorVel Corp (CRVL) Valuation: PE, PB & Fair Value Analysis
CorVel Corp (CRVL) currently holds a valuation score of 6.80, placing it 64th out of 76 in the Healthcare Providers & Services industry. The company's P/E ratio stands at 29.27, which is significantly lower than its recent high but considerably higher than its recent low. However, relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
CorVel (NASDAQ: CRVL) details 2026 meeting, new CEO and say-on-pay
CorVel Corporation has announced its 2026 Annual Meeting of Stockholders for August 6, 2026, in Milwaukie, Oregon, where shareholders will vote on electing six directors, ratifying Haskell & White LLP as the independent auditor, and a non-binding advisory vote on executive compensation. The company will also undergo a planned leadership transition on July 1, 2026, with long-time CEO Michael G. Combs moving to Executive Chair and Sarah A. Scott becoming the new Chief Executive Officer and President. The proxy statement details the company's executive compensation philosophy, which links pay to financial performance and strategic objectives, and outlines its corporate governance practices.
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
CorVel Corporation has launched Marketwise Repricing™, a new solution designed to optimize medical cost containment by integrating market-based reimbursement methods into existing bill review workflows. This data-driven approach aims to capture additional savings, especially for out-of-network bills and in states with limited fee schedules, by providing more consistent and supportable pricing outcomes based on real-world reimbursement data. The solution is intended to complement traditional cost containment measures without increasing administrative burden for clients.
CRVL Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of CorVel Corp (CRVL), detailing its revenue breakdown, profitability margins, and competitor comparison. The company generates most of its revenue from Patient Management Services and exhibits strong profitability with a net margin of 12.48% and ROE of 30.81%. It competes with BWIN and NP in the Healthcare Facilities & Services industry.
CorVel Corp (CRVL) Financial Health: Profitability & Balance Sheet Analysis
This article provides an analysis of CorVel Corp's (CRVL) financial health, highlighting its robust status and high operating efficiency. The company achieved a financial score of 9.19, ranking it highly within the Healthcare Providers & Services industry. Key financial indicators show a 7.36% year-over-year increase in quarterly revenue and a 17.45% increase in net profit.
CorVel Corp (CRVL) Institutional Confidence
CorVel Corp (CRVL) has an institutional shareholding score of 5.00, placing it 49th out of 76 in the Healthcare Providers & Services industry. Institutional shareholders currently hold 53.54% of the shares, a decrease of 3.12% quarter-over-quarter. The largest institutional shareholder is James Simons, holding 3.18% of shares outstanding.
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
CorVel Corporation has introduced Marketwise Repricing™, a new solution designed to optimize medical cost containment by integrating market-based reimbursement methods into existing bill review workflows. This data-driven approach aims to capture additional savings, especially for out-of-network bills and in states with limited fee schedules, by providing more consistent and supportable pricing outcomes based on real-world data. The solution is intended to enhance current strategies without increasing administrative burden for clients.
CorVel Corp (CRVL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for CorVel Corp (CRVL), detailing its performance by business segments and regional contributions. As of the latest update on April 6, the company's revenue is primarily generated from Patient Management Services and Network Solution Services, exclusively within the United States. The data reflects revenue figures for Q3 FY2026.
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
CorVel Corporation announced the launch of Marketwise Repricing™, a new market-based medical bill repricing solution. This data-driven solution aims to optimize cost management and integrate seamlessly with existing bill review programs, capturing additional savings where traditional methods fall short. Marketwise Repricing utilizes real-world reimbursement data to provide more consistent and supportable pricing outcomes, especially beneficial for out-of-network bills and regions without established fee schedules.
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
CorVel Corporation (Nasdaq: CRVL) has launched Marketwise Repricing™, a new solution designed to optimize medical cost containment by integrating market-based reimbursement methods into existing bill review workflows. This system aims to capture additional savings by reflecting local market conditions and is particularly useful for out-of-network bills or in states with limited fee schedules. It promises more consistent and supportable pricing outcomes without adding administrative burden to clients.
Corvel Corp CIO Maxim Shishin sells $136,327 in shares
Maxim Shishin, CIO at CORVEL CORP (CRVL), sold 2,250 shares for $136,327 on June 12, 2026, after exercising stock options. The company's stock has declined by 43% in the past year, though InvestingPro 분석 rates it as undervalued with "GREAT" financial health. CorVel also reported strong Q4 2026 results, with a 7% revenue increase and 19.6% EPS growth.
Corvel Corp CIO Maxim Shishin sells $136,327 in shares By Investing.com
Maxim Shishin, CIO of Corvel Corp (NASDAQ: CRVL), sold 2,250 shares for $136,327 on June 12, 2026, after exercising non-qualified stock options. Despite a recent stock decline, InvestingPro analysis indicates the stock is undervalued with a "GREAT" financial health score. This transaction follows strong Q4 2026 financial results for CorVel, showcasing a 7% revenue increase and a 19.6% rise in EPS.
Corvel Corp CIO Maxim Shishin sells $136,327 in shares By Investing.com
Maxim Shishin, CIO of Corvel Corp (NASDAQ:CRVL), sold 2,250 shares for $136,327 after exercising non-qualified stock options. This sale occurred on June 12, 2026, and leaves Shishin with 7,050 shares. The company recently reported strong Q4 2026 financial results with a 7% revenue increase and a 19.6% rise in EPS.
CorVel (CRVL) CEO Michael Combs sells 500 shares in open-market trade
CorVel Corp's CEO & President Michael G. Combs sold 500 shares of company stock at $60.79 per share in an open-market transaction on June 12, 2026. Following this sale, Combs directly holds 12,322 shares of CorVel common stock. This insider activity was reported in a Form 4 filing, indicating a net sale of $30,395 worth of stock.
CorVel (CRVL) CIO exercises options and sells 2,250 shares
CorVel Corp's Chief Information Officer, Maxim Shishin, engaged in an exercise-and-sell transaction. He exercised 2,250 Non-Qualified Stock Options at $52.647 per share and simultaneously sold 2,250 common shares at an average price of $60.59 per share. Following these transactions, Shishin directly holds 7,050 shares of CorVel common stock.
CorVel (NASDAQ: CRVL) director exercises 9,000 options, delivers shares for taxes
CorVel Corp director R. Judd Jessup exercised 9,000 non-qualified stock options at $14.44 per share on June 11, 2026. In connection with this, 2,153 shares valued at $60.79 per share were delivered to cover the exercise price and related tax liability. After the transactions, Jessup directly held 118,645 shares of CorVel common stock, reflecting a routine compensation-related event rather than an open-market purchase or sale.
Maxim Shishin plans sale of 2,250 CRVL shares via option (CRVL)
Maxim Shishin has filed a Form 144 notice indicating a proposed sale of 2,250 shares of CorVel Corp (CRVL) common stock through a stock option exercise on June 12, 2026. The filing also notes a previous sale of 2,400 shares on March 16, 2026, which generated proceeds of $129,603.84. This regulatory filing provides transparency regarding the insider's planned stock transactions handled by Morgan Stanley Smith Barney LLC.
Corvel Corp CEO Michael Combs sells $1.28m in stock By Investing.com
Corvel Corp (NASDAQ:CRVL) CEO Michael G. Combs sold 21,000 shares of the company's common stock for a total of $1.28 million between June 9 and June 11, 2026. Following these transactions, Mr. Combs now holds 12,822 shares. Despite the insider sale, InvestingPro analysis suggests CRVL is undervalued, and the company recently reported strong Q4 2026 financial results with a 7% revenue increase and a 19.6% rise in EPS.
Corvel Corp CEO Michael Combs sells $1.28m in stock
Corvel Corp CEO and President Michael G. Combs sold 21,000 shares of company stock between June 9 and June 11, 2026, totaling over $1.28 million. Following these transactions, Combs holds 12,822 shares. Despite the insider sale, Corvel Corp recently reported strong Q4 2026 financial results with increased revenue and EPS, and InvestingPro analysis suggests the stock is undervalued.
Corvel Corp CEO Michael Combs sells $1.28m in stock
Corvel Corp CEO Michael Combs sold 21,000 shares of company stock between June 9 and June 11, 2026, totaling $1.28 million. Following these sales, Combs retains 12,822 shares. This insider selling occurred despite the company's strong Q4 2026 financial results, which included a 7% revenue increase and a 19.6% rise in EPS.
Corvel Corp CEO Michael Combs sells $1.28m in stock By Investing.com
Corvel Corp CEO Michael Combs sold 21,000 shares of the company's common stock over three days in June 2026, totaling $1.28 million. Despite these insider sales, CorVel reported strong Q4 2026 financial results with increased revenue and EPS, and InvestingPro analysis suggests the stock is undervalued. This activity occurs even as management aggressively buys back shares.
CorVel (CRVL) CEO Michael Combs sells 21,000 shares in open-market trades
CorVel Corp's CEO and President, Michael G. Combs, sold a total of 21,000 shares of common stock in three separate open-market transactions between June 9 and June 11. After these sales, Combs directly holds 12,822 shares. The transactions appear as straightforward sales, with no derivative exercises or disclosed Rule 10b5-1 trading plan.
Corvel Corp director Michael Jeffrey J. sells $548,834 of shares By Investing.com
Corvel Corp director Michael Jeffrey J. sold 9,000 shares of the company's common stock for $548,834 after exercising stock options. The sale occurred on the same day he acquired an equal number of shares through options at a lower price. Following these transactions, Mr. Michael directly holds 559,721 shares of Corvel Corp.
Corvel Corp CEO & president Michael Combs sells $421k in stock
Michael G. Combs, CEO & President of Corvel Corp (NASDAQ:CRVL), sold 7,000 shares of common stock for approximately $421,558 on June 8, 2026. This transaction follows strong financial results for Q4 2026, where the company reported a 7% revenue increase and 19.6% EPS growth. Despite the insider sale, InvestingPro analysis suggests the company is undervalued, with management also aggressively buying back shares.
Corvel Corp CEO & president Michael Combs sells $421k in stock
Corvel Corp CEO & President Michael Combs sold 7,000 shares of company stock for approximately $421,558 on June 8, 2026. This transaction occurred despite the company's stock being down 45% over the past year, though an InvestingPro analysis suggests it is undervalued. The sale happened concurrently with management's aggressive share buyback program, indicating internal dynamics within the company's financial strategy.
Insider Sell: Michael Combs Sells 7,000 Shares of CorVel Corp (C
Michael Combs, CEO & President of CorVel Corp (CRVL), sold 7,000 shares of the company on June 8, 2026, reducing his total holdings to 33,822 shares. Over the past year, the company has seen 18 insider sells and no insider buys. Despite the insider selling, CorVel Corp appears significantly undervalued with a price-to-GF-Value ratio of 0.6, trading at $60.22 against a GF Value of $101.12.
CorVel (CRVL) CEO Michael Combs sells 7,000 shares in open-market trade
CorVel Corp's CEO, Michael G. Combs, reported an open-market sale of 7,000 shares of common stock on June 8, 2026, at an average price of $60.2226 per share, totaling approximately $422,000. Following this transaction, Combs directly holds 33,822 shares. The sale was executed under a Rule 10b5-1 plan, and the detail was filed in a Form 4 with the SEC.
[144] CORVEL CORP SEC Filing
This SEC filing (Form 144) for CORVEL CORP (CRVL) indicates a proposed sale of 9000 common shares by an individual. The shares were acquired via stock option on August 4, 2016, and have an aggregate market value of $545,130 based on a share price from the filing date. The sale is intended to occur on June 9, 2026, through UBS Financial Services Inc. on NASDAQ.
CorVel Rings the Nasdaq Stock Market Opening Bell
CorVel (Nasdaq: CRVL), a prominent provider of risk management solutions, recently rang the Opening Bell at the Nasdaq MarketSite in Times Square. The ceremony featured CorVel's President and CEO, Michael Combs, marking the occasion. This event is part of Nasdaq's daily tradition of market open and close ceremonies held globally.
CRVL (NASDAQ: CRVL) Form 144 shows 28,500 shares offered for resale
CorVel Corp (NASDAQ: CRVL) has filed a Form 144 indicating a proposed sale of 28,500 shares of common stock, valued at $1,706,152.50, which are linked to previously exercised options from February 2022. The filing also notes a prior sale of 8,013 shares by Michael G. Combs for $432,702.00 in March 2026. This disclosure is a routine regulatory procedure for planned and recent transactions, with Morgan Stanley Smith Barney LLC identified as the broker for the proposed sale.
CorVel Corp stock (US2210061099): Share gains after CEO transition news
CorVel Corp's shares gained 1.44% following the announcement of a CEO and president transition, with Sarah Scott taking the helm and Michael G. Combs becoming executive chair. The company, which specializes in healthcare services and claims management, operates in a stable niche within the US economy. Investors will be watching how this leadership change impacts execution and margins in the coming quarters, especially given the stock's recent cautious trading despite longer-term gains.
CRVL - Corvel Corp Stock Price and Quote
This article provides a detailed overview of Corvel Corp (CRVL) stock, including its latest stock price, financial metrics, performance indicators, and recent news and insider transactions. It covers key financial data such as market cap, income, sales, P/E ratio, and insider/institutional ownership, alongside a chronological list of company announcements and executive stock sales.
Precision Trading with Corvel Corp. (CRVL) Risk Zones
This article provides a precision trading analysis for Corvel Corp. (CRVL), highlighting near-term weak sentiment within a broader long-term weak bias despite mid-term strength. It outlines three distinct AI-generated trading strategies: a Long Position Trading Strategy, a Momentum Breakout Strategy, and a Short Risk Hedging Strategy, complete with entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal insights for near-term, mid-term, and long-term horizons, advising on current sentiment and risk parameters.
CorVel Corp. Stock Hits Day Low of $56.31 Amid Price Pressure
CorVel Corp. experienced a significant stock decline, reaching an intraday low of $56.31 and dropping by 7.53%. Despite a 48.14% drop over the past year, the company maintains a strong financial position, being net-debt-free with a 29.09% return on equity and 63.2% institutional holdings. Net profit growth was robust at 17.45%, alongside $155.64 million in operating cash flow.
Precision Trading with Corvel Corp. (CRVL) Risk Zones
This article provides an AI-driven analysis of Corvel Corp. (CRVL) focusing on risk zones and trading strategies. It highlights near-term weak sentiment, mid-term strength, and mentions no clear price positioning, suggesting compelling upside potential due to the absence of resistance levels above the current price. Three institutional trading strategies are outlined for different risk profiles: Position Trading (Long), Momentum Breakout, and Risk Hedging (Short).
What Does CorVel's Leadership Transition Signify
CorVel Corporation announced a leadership transition with Sarah Scott becoming CEO and President and Michael G. Combs transitioning to Executive Chair. This move aims to blend continuity with fresh operational leadership, focusing on accelerating AI-driven solutions and the "prepayment-first" CERIS strategy. Despite a significant recent stock price decline and a "Sell" rating, the company shows underlying financial strength with 7% revenue growth in Q3 2025.
CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth
CorVel Corporation is celebrating its 35th anniversary as a publicly traded company on the Nasdaq Stock Market. Chairman, President, and CEO Michael Combs will commemorate this milestone by ringing the Nasdaq opening bell. The company highlights its consistent strategy of technology investment, operational discipline, and commitment to people as key to its sustained market performance and financial strength over three decades.
CorVel Corp stock (US2210061099): marks 35 years on Nasdaq and highlights innovation plans
CorVel Corp (CRVL) recently celebrated its 35th anniversary on Nasdaq, highlighting its sustained growth and focus on innovation in healthcare technology and claims management. The company, which boasts a debt-free balance sheet and a market capitalization of USD 5.68 billion, emphasised its long-term financial performance, including a 14% compound annual revenue growth rate and a 17% average annual share price increase over the last 30 years. CorVel plans to continue leveraging technology for solutions in workers' compensation, auto, liability, and health markets.
CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth
CorVel Corporation is celebrating its 35th anniversary as a publicly traded company on the Nasdaq Stock Market. Chairman, President, and CEO Michael Combs will commemorate this milestone by ringing the Nasdaq opening bell. The company highlights its consistent strategy of technology investment, operational discipline, and commitment to its people, which has led to strong market performance and sustained growth.
CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth
CorVel Corporation will celebrate its 35th anniversary as a publicly traded company on the Nasdaq Stock Market by ringing the opening bell in New York City on June 9, 2026. This milestone highlights CorVel's consistent execution, financial discipline, and commitment to technology investment, positioning the company for continued innovation and growth. Chairman, President, and CEO Michael Combs emphasized the strength of their people, long-term vision, and agility as key factors in their sustained success.
CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth
CorVel Corporation celebrated its 35th anniversary as a publicly traded company on Nasdaq, with its executive leadership team ringing the Nasdaq opening bell. The company highlighted its strong market performance, focusing on technology investment, operational discipline, and a commitment to its people. CEO Michael Combs emphasized the company's long-term vision, disciplined execution, and continuous innovation, positioning CorVel for future growth.
CorVel (NASDAQ: CRVL) elevates Sarah Scott to CEO as Combs becomes Executive Chair
CorVel Corporation announced a leadership transition, appointing Sarah Scott as CEO and President, effective July 1, 2026. Michael G. Combs, the current CEO, will transition to the new role of Executive Chair. This move aims to ensure leadership continuity, with Scott bringing over 26 years of experience within the company, while Combs will advise and support long-term strategic planning.
After 26 years at CorVel, Sarah Scott is set to become CEO
CorVel (NASDAQ:CRVL) announced that Sarah Scott, who has been with the company for over 26 years, will take over as CEO and President on July 1, 2026. She succeeds Michael G. Combs, who will transition to the role of Executive Chair and continue to advise the company. This leadership change is described as part of CorVel's long-term succession planning and reflects Scott's experience in advancing the company's operational performance and strategic initiatives.
CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
CorVel has announced that Sarah Scott will become the new CEO and President, effective July 1, 2026, succeeding Michael G. Combs. Mr. Combs, who led the company through significant growth since 2017, will transition to the role of Executive Chair to support the leadership transition and long-term vision. Ms. Scott, with over 26 years at CorVel, is currently the Executive Vice President of Product and Corporate Services.
Corvel VP Jennifer Yoss sells $121,979 in company stock By Investing.com
Jennifer Yoss, VP of Accounting at Corvel Corp (NASDAQ:CRVL), sold 1,999 shares of company stock for approximately $121,979 on May 26, 2026, after acquiring them through exercised stock options for about $101,811. Despite a 46% stock price drop over the past year, InvestingPro analysis indicates CRVL is undervalued. The company recently reported strong Q4 2026 financial results with a 7% revenue increase and a 19.6% rise in EPS.
Corvel VP Jennifer Yoss sells $121,979 in company stock
Jennifer Yoss, VP of Accounting at CORVEL CORP (NASDAQ:CRVL), sold 1,999 shares of company stock for approximately $121,979 on May 26, 2026. This transaction followed her acquisition of the same number of shares through stock option exercises valued at about $101,811. Despite a recent 46% stock price decline, InvestingPro analysis suggests CRVL is undervalued, and the company recently reported strong Q4 2026 results with a 7% revenue increase and 19.6% EPS rise.
[Form 4] CORVEL CORP Insider Trading Activity
CorVel Corp's Vice President of Accounting, Jennifer Yoss, recently exercised stock options and sold the resulting shares. On May 26, 2026, she acquired 1,999 shares through options at strike prices of $49.63 and $51.997, then sold all 1,999 shares in open-market transactions for an average price of $61.0205. Following these transactions, her direct ownership in CorVel common stock stands at 2,173 shares.
How CorVel's AI strategy is reshaping workers' comp claims management
CorVel Corp is integrating artificial intelligence into its daily workflows to transform workers' compensation claims management. The company's CorVel Connected™ platform, embedded within CareMC, aims to reduce administrative burdens and provide actionable insights while enhancing human communication and advocacy. This strategy emphasizes thoughtful AI adoption and strong change management to improve claim outcomes, manage costs, and support staff retention.
[144] CORVEL CORP SEC Filing
This article details a Form 144 SEC filing by CorVel Corp (CRVL) on May 26, 2026, indicating a proposed sale of securities. The filing specifies the class of securities to be sold (Common), the broker (Morgan Stanley Smith Barney LLC), and the aggregate market value of the securities. It also provides information on the acquisition of these securities, noting a stock option exercise by the issuer on the same date.
